Eli Lilly's Latest Setback Could Portend an Unexpected Headwind for the Stock
29/10 11:30
Everyone knows that big pharma companies like Eli Lilly (NYSE: LLY) need to get regulators to agree that their medicines are safe and effective before they can make any money. But regulators aren't the only group the companies need appease before shareholders can see a return....